Status:
COMPLETED
Mortality Post-TAVI and Correlation With Haemodynamic Parameters.
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
Brief Summary
Until a few years ago the only interventional option available for severe aortic stenosis was surgical aortic valve replacement. About a decade ago, a novel percutaneous technique was applied for the ...
Detailed Description
Aortic valve stenosis is the most prevalent valvulopathy in the developed world countries. Until a few years ago the only interventional option available for severe aortic stenosis was surgical aortic...
Eligibility Criteria
Inclusion
- All patients with TAVI within the Royal Brompton \& Harefield NHS Foundation Trust
Exclusion
- None
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT03769545
Start Date
January 1 2008
End Date
December 31 2017
Last Update
December 7 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.